QUR

Prescription Spectacle Lenses To Reduce The Progression Of Myopia

Product code
QUR
Device name
Prescription Spectacle Lenses To Reduce The Progression Of Myopia
Device class
Class 2
21 CFR
21 CFR 886.5845
Medical specialty
Ophthalmic
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

Prescription spectacle lenses to reduce the progression of myopia consist of spectacle lenses with additional physical optical design lens elements. In addition to optical correction of myopic refractive error, these lenses are intended to be used by children who have myopia to reduce the rate of myopia progression. The lenses are mounted within a spectacle frame classified under § 886.5842.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2025-09-25.

NumberDecision dateApplicantDevice nameSummary
DEN2500162025-09-25Essilor Of America, Inc.Essilor® Stellest®
Official FDA classification page: QUR
Classification and pathway per current FDA publications. Data from openFDA (CC0).